Enjoy complimentary customisation on priority with our Enterprise License!
The Global 3D Bioprinting Market size is estimated to grow by USD 2.02 billion, at a CAGR of 19.94% between 2022 and 2027. The growth of the market depends on several factors, including the rising cost efficiency and enhanced productivity, the advancements in technology, and the increased demand for personalized or customized orthopaedic devices. Challenges such as high initial costs to set up a 3D printing facility, the inability of researchers to combine vascular supply in printed tissues and organs, and the limited availability of suitable biomaterials might hamper the growth of the market. Nevertheless, trends such as developments in scaffold-free bioprinting, bio-fabrication of complex tissues, and the rising focus on R&D of 3D bioprinting will boost the growth of the market.
To learn more about this report, Request Free Sample
This market research and growth report extensively covers market segmentation by application (human tissue and organ generation, medical testing, dental, prosthetics, and others), solution (3d bioprinters, bioprinting materials, and services and ancillary equipment), and geography (North America, Europe, Asia, and Rest of World (ROW)).
The market is driven by the aging population's increasing demand for advanced medical treatments. Innovations like biotherapeutics and artificial organs propel market growth. Companies like Viscient Biosciences and Stratasys pioneer inkjet-based and laser-assisted bioprinting technologies, enabling precise drug delivery and organ fabrication. However, challenges like ensuring proper respiratory epithelium integration and preventing potential damage during the printing process persist. Despite these hurdles, 3D bioprinting holds immense promise in revolutionizing healthcare by offering personalized medical solutions and addressing critical organ shortages. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
Market expansion is notably fueled by advancements in 3D bioprinting technology, characterized by ongoing improvements in bio-ink formulations, printing methods, and tissue engineering strategies. These enhancements facilitate the creation of intricate tissue structures, revolutionizing regenerative medicine. Novel bio-ink formulations enhance cell survival and tissue fusion, enabling personalized structures for patients. Enhanced printing methods, utilizing multiple printheads, enable precise deposition of various cell types and materials, yielding intricate tissue constructs.
Further, innovative tissue engineering methods, such as bioprinting on pre-pasteurized substrates, offer promising options for robust tissue fabrication. Consequently, 3D bioprint technology fosters market growth, pushing boundaries in regenerative medicine and personalized healthcare. Expectations for substantial market expansion remain high, driven by these transformative advancements.
The fabrication of complex tissues is a primary trend in the market share. The focus on fabricating complex tissues and multi-organ complexes is a prominent trend in the market. To create functioning tissues with complex structures, researchers are investigating the simultaneous printing of several cell types, extracellular matrix, and growth hormones.
Moreover, the development of multi-organ complexes and complex tissues that can be printed holds great promise for the future of personalized healthcare and regenerative medicine. In view of that fact, this trend is anticipated to have a strong impact on the market growth and trends over the forecast period and will be instrumental in its growth.
The inability of researchers to combine vascular supply in printed tissues and organs is a major challenge in the market. Although the market has witnessed breakthroughs over the years, it is far from bioprinting a fully functional organ or tissue for transplant. The researchers are successful in bioprinting parts of an organ or tissue that has cells fully capable of performing their dedicated functions. However, they have not been able to combine vascular veins in the printed organs, though they can be printed separately. The bioprinted product needs the vascular vein network and the necessary blood flow in it to work.
However, without the vascular system, the thickness of the tissue is limited. Growth in the focus market would be limited until an intact organ has been developed and readiness for transplantation is achieved. It does not envisage that this technology will be commercially available to end users in the future. Consequently, it is expected that a challenge to the growth of the market in focus over the forecast period will be researchers' failure to combine blood vessel supply for printing tissues and organs.
The market trends and analysis report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, market analysis and report also include key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.
Customer Landscape
The market is driven by the ageing population's increasing demand for advanced medical treatments. Innovations like biotherapeutics and artificial organs propel market growth. Companies like Viscient Biosciences and Stratasys pioneer inkjet-based and laser-assisted bioprinting technologies, enabling precise drug delivery and organ fabrication. However, challenges like ensuring proper respiratory epithelium integration and preventing potential damage during the printing process persist. Despite these hurdles, 3D bioprinting holds immense promise in revolutionizing healthcare by offering personalized medical solutions and addressing critical organ shortages.
The market share growth by the human tissue and organ generation segment will be significant during the forecast period. Human tissue and organ generation can reduce the waiting period for patients who need organ donors. The other benefit of using 3D-bioprinted organs is that the chances of the patient's body rejecting the implant are reduced to a bare minimum. Organ implants from donors are often rejected by the patient's body leading to complications post-implantation.
Get a glance at the market contribution of various segments View the PDF Sample
This human tissue and organ generation shows a gradual increase in the market share of USD 221.27 million in 2017 and continue to grow by 2021. Although the technology for printing organs is still in the developmental stage, laboratories, and research organizations have successfully developed a human kidney. However, bio-printed organs were not ready for human trials till 2017. The demand for 3D bioprinting in the Human tissue and organ generation application is expected to increase and hence drive the growth of the market in focus during the forecast period.
For more insights on the market share of various regions Download PDF Sample now!
North America is estimated to contribute 31% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period. North America accounted for the largest revenue share of the global market in 2022. The US and Canada are the significant revenue contributors to the market in focus in North America. The growth of the market in focus in the region can be attributed to improved healthcare infrastructure, high adoption of 3D bioprinting technologies in healthcare facilities, and the presence of established companies.
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.
3D Bioprinting Solutions - The company offers 3D bioprinting such as Fabion 2 and Viscoll.
The market growth and forecasting report also includes detailed analyses of the competitive landscape of the market and information about 15 market companies, including:
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD Billion" for the period 2023 to 2027, as well as historical data from 2017 to 2021 for the following segments
The market is at the forefront of medical innovation, addressing critical healthcare needs driven by the aging population. With advancements in technology and skilled professionals, 3D bioprinting enables the creation of intricate structures like respirators, ventilators, and biotherapeutic implants. This transformative technology facilitates the precise printing of artificial skin, hair follicles, and even organ transplants from donor organs or natural tissues, reducing the reliance on immunosuppressants. Through processes like magnetic levitation and extrusion-based printing, bioprinters fabricate living tissues with high cell viability, crucial for applications such as toxicity screening and vascular muscle printing. Moreover, 3D bioprinting plays a pivotal role in drug development and toxicity screening, offering insights through patent analysis and bioassays. As the market evolves, the integration of metals and plastics expands the possibilities for 3D-printed skin and bone grafts, driving advancements towards a future of personalized medicine and regenerative therapies.
Further, the market thrives on technological advancements, offering groundbreaking solutions in bioengineering and human cell regeneration. From intricate nasopharyngeal swab to precision BioAssay, 3D printers revolutionize medical diagnostics and drug development. This innovative approach extends to manufacturing medical pills tailored to individual needs, shaping buying behaviour in the healthcare sector. With meticulous process control, bioprinters ensure the viability of living cells and the precise deposition of drug molecules, propelling research in personalized medicine. Utilizing extrusion-based techniques, bioprinting paves the way for unparalleled advancements in tissue engineering and regenerative therapies. As the market evolves, the integration of 3D bioprinting continues to redefine healthcare, offering hope for improved patient outcomes and transformative medical treatments.
Market Scope |
|
Market Report Coverage |
Details |
Page number |
170 |
Base year |
2022 |
Historic period |
2017-2021 |
Forecast period |
2023-2027 |
Growth momentum & CAGR |
Accelerate at a CAGR of 19.94% |
Market growth 2023-2027 |
USD 2.02 billion |
Market structure |
Fragmented |
YoY growth 2022-2023(%) |
19.82 |
Regional analysis |
North America, Europe, Asia, and Rest of the World (ROW) |
Performing market contribution |
North America at 31% |
Key countries |
US, Canada, Germany, China, and Japan |
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Key companies profiled |
3D Bioprinting Solutions, 3D Systems Corp., Advanced Solutions Inc., Aspect Biosystems Ltd., BICO Group AB, CollPlant Biotechnologies Ltd., Cyfuse Biomedical K.K., Desktop Metal Inc., Foldink, GE Healthcare Technologies Inc., Hangzhou Jienuofei Biotechnology Co. Ltd., Inventia Life Science Pty Ltd., Organovo Holdings Inc., Pandorum Technologies Pvt. Ltd., Poietis, Precise Bio Inc., regenHU Ltd., and ROKIT Healthcare Inc. |
Market dynamics |
Parent market growth analysis, Market Forecasting, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the market forecast period. |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this market research report to meet your requirements.
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Application
7 Market Segmentation by Solution
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.